Biohaven Pharmaceutical Holding Company Ltd. (NYSE:BHVN) went down by -1.09% during the previous trading session, and it is maintaining the win ahead of Tuesday’s trading session. The share price of the Biotechnology giant went up by $72.89 to trade ended Tuesday trading at $73.69. This is down from the $73.69 price recorded on Monday’s trading session. Thanks to this latest performance, BHVN is closer to the higher price 52-week target of $109.00 and further from the lowest price target of $50.00. Its performance from the start of the year has also been positive, with BHVN up by 33.89% year-to-date.
Biohaven Pharmaceutical Holding Company Ltd. (BHVN) started the day trading at $74.95 and recorded an intraday high of $75.53. It also recorded an intraday low of $72.02 during Tuesday’s trading session. Biohaven Pharmaceutical Holding Company Ltd. is a very active stock that recorded a trading volume that is more than 0.01% of the average daily trading volume on Tuesday. The stock’s trading volume on Tuesday was 941068, which is more than 0.01 of the total average daily trading volume of 940.99K.
Biohaven Pharmaceutical Holding Company Ltd. (NYSE:BHVN) 2020 Performance Impressive
The increase in BHVN’s stock price on Tuesday saw its overall performance boost over the past few months. We can quantify the performance of the stock so far this year using a few metrics. The 52-week high price of BHVN currently stands at $76.40, which is higher than the current trading price of the stock by 4.59%. However, BHVN’s current trading price is -174.44% lower than the 52-week low price of $26.56. In terms of trading volume, Biohaven Pharmaceutical Holding Company Ltd. currently experienced healthy participation during the last trading session. 941068 shares of Biohaven Pharmaceutical Holding Company Ltd. were traded on the stock exchange on Tuesday, which is more than 0.01% of the 940.99K average trading volume of the stock.
The performance of the stock has been positive over the past year. BHVN’s performance over the past one year has seen it surge by 83.14%, while the stock has gone up by 37.09% in the last six months. The quarterly performance of BHVN currently stands at 114.32%, and it is up by 24.85% in the last month. The only positive figure was from the weekly performance, which currently reads 7.14%. At the time of writing BHVN’s report, the company has a total market cap of $4.36B, making it one of the largest publicly-traded companies in the world.Biohaven Pharmaceutical Holding Company Ltd. also has over 647 employees all over the world.
BHVN Insider Activities
For Biohaven Pharmaceutical Holding Company Ltd., insiders hold 97.21% of all company shares. The insider transactions over the past six months are down by 0.00%. During that period, insiders bought 986,289 shares in 24 transactions. In that same period, insiders sold 1,228,455 of their shares in 53 transactions. After these transactions, insiders at Biohaven Pharmaceutical Holding Company Ltd. now hold 8.14M shares, which is over 97.21% of the total company stocks. Institutional investors currently hold a large chunk of the BHVN shares, as they control 13.91% of the company’s total stock.
BHVN Fundamental Analysis
For Biohaven Pharmaceutical Holding Company Ltd., the stock’s diluted earnings per share (EPS) stands at -12.62. In the coming year, analysts expect the EPS to be -6.69. The stock’s EPS growth this year is -77.40%, with analysts expecting almost a 1 growth in the earnings per share next week.
It has a net profit margin of 0.00%. The gross margin of the company is 63.20%.
BHVN Analysts Prediction
and Canaccord Genuity reiterate their Buy position on the stock ($89 and $84).
Canaccord Genuity and Goldman also believe that Biohaven Pharmaceutical Holding Company Ltd.’s stock is outperforming at the moment.
At the moment, Biohaven Pharmaceutical Holding Company Ltd.’s Total Debt to Equity ratio stands at 2.36, and they have a long-term Debt to Equity ratio of 2.36.
BHVN Technical Analysis
The Simple Moving Average (SMA) is one of the most powerful technical indicators. The 20-day Simple Moving Average of BHVN currently stands at 9.19%, while the SMA50 is 34.81%. The biggest one is the SMA200, which is currently reading 50.42% ahead of Tuesday’s trading session. The Relative Strength Index of this stock is 66.78.